login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
CODEX DNA INC (DNAY) Stock News
USA
- NASDAQ:DNAY -
US1920031010
-
Common Stock
1.3
USD
+0.1 (+8.33%)
Last: 1/3/2023, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
DNAY Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Telesis Bio
Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results
3 years ago - By: Benzinga
- Mentions:
QTNT
DERM
RLMD
KALA
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
3 years ago - By: Telesis Bio
Telesis Bio Inc. Reports Third Quarter 2022 Financial Results
3 years ago - By: Codex DNA, Inc.
Codex DNA kündigt Plan zur Umfirmierung in Telesis Bio an
3 years ago - By: Benzinga
Codex DNA: Q2 Earnings Insights
3 years ago - By: Telesis Bio
Telesis Bio to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 8
3 years ago - By: Telesis Bio
Telesis Bio und Cellibre kündigen Zusammenarbeit an, um die Entwicklung des künftigen BioXp® DBC-Instruments zu optimieren
3 years ago - By: Telesis Bio
Telesis Bio et Cellibre annoncent une collaboration pour optimiser le développement du futur instrument BioXp® DBC
3 years ago - By: Telesis Bio
Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument
3 years ago - By: Codex DNA, Inc.
Codex DNA annonce son intention de changer son nom d'entreprise en Telesis Bio
3 years ago - By: Codex DNA, Inc.
Codex DNA weitet Anwendung der firmeneigenen Fehlerkorrekturtechnologie aus
3 years ago - By: Codex DNA, Inc.
Codex DNA étend l'application de la technologie exclusive de correction des erreurs
3 years ago - By: Codex DNA, Inc.
Codex DNA Expands Application of Proprietary Error Correction Technology
3 years ago - By: Codex DNA, Inc.
Codex DNA Showcases Next Generation Automated Synthetic Biology Workstation at World of Technology & Science in Utrecht, Netherlands
3 years ago - By: Codex DNA, Inc.
Codex DNA presenteert Next Generation Automated Synthetic Biology Workstation op World of Technology & Science in Utrecht, Nederland
3 years ago - By: Codex DNA, Inc.
Codex DNA präsentiert automatisierte synthetische Biologie-Workstation der nächsten Generation auf der World of Technology & Science in Utrecht, Niederlande
3 years ago - By: Codex DNA, Inc.
Codex DNA présente sa prochaine génération de postes de travail de biologie synthétique automatisée lors de la conférence World of Technology & Science à Utrecht, aux Pays-Bas
3 years ago - By: Codex DNA, Inc.
Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation
3 years ago - By: Codex DNA, Inc.
Codex DNA Reports Second Quarter 2022 Financial Results
3 years ago - By: Investor's Business Daily
- Mentions:
BNTX
PFE
MRNA
AKRO
...
Is Pfizer Stock A Buy Or A Sell As Its Covid Vaccine Faces A New Lawsuit?
3 years ago - By: InvestorPlace
- Mentions:
XCUR
REVB
MARK
SCWO
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
3 years ago - By: InvestorPlace
- Mentions:
QTNT
DTIL
WKEY
REV
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Please enable JavaScript to continue using this application.